Amicus Therapeutics Inc.

Amicus Therapeutics Appoints Margaret G. McGlynn, R.Ph., to Board of Directors.
Vaccine Weekly; 11/18/2009; 599 words; Amicus Therapeutics (NASDAQ:FOLD) announced...for Merck & Co., Inc (see also Amicus Therapeutics). John F. Crowley...Board." Keywords: Amicus Therapeutics, Infectious Diseases...Biotechnology, Merck & Company Inc., Pharmaceutical...

FoldRx Kicks Off Phase II/III Against Genetic Neuropathy.
BIOWORLD Today; 11/3/2009; 1162 words; ...experience, too. With Genome Therapeutics Corp. (now Oscient Pharmaceuticals...news lately include Biogen Idec Inc., of Cambridge, Mass., and...is Cranbury, N.J.-based Amicus Therapeutics Inc., which this spring - six months...

Biogen Idec Authorizes $3B Stock Buy-Back.
BIOWORLD Today; 11/3/2009; 1334 words; ...Tuesday, and Amgen Inc. authorized a...financing news: o Acorda Therapeutics Inc., of Hawthorne...Proceeds will support Amicus' Prolactis technology...Avalon Pharmaceuticals Inc., of Germantown...2007.) o Chemokine Therapeutics Corp., of Vancouver...

Clinic Roundup.
BIOWORLD Today; 11/3/2009; 840 words; o Affymax, Inc., of Palo Alto, Calif., initiated a clinical trial to evaluate...Phase II trials to treat anemia in patients with CKD and cancer. o Amicus Therapeutics, of Cranbury, N.J., said the Committee for Orphan Medicinal...

FoldRx Gets Up To $22M From Cystic Fibrosis Foundation.
BIOWORLD Today; 11/3/2009; 1186 words; ...770; Altus Pharmaceuticals Inc., which is in Phase III with ALTU-135; and PTC Therapeutics Inc., which is in Phase II with...working on protein misfolding is Amicus Therapeutics Inc., of Cranbury, N.J., which...